Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza (Q28201381)

Expert Opinion on Investigational Drugs

Europe PubMed Central

title

Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza (English)

0 references

2

Donald F Smee

0 references

author name string

Robert W Sidwell

series ordinal

1

0 references

language of work or name

English

0 references

publication date

June 2002

0 references

published in

0 references

volume

11

0 references

issue

6

0 references

page(s)

859-69

0 references

cites work

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

1 reference

https://api.crossref.org/works/10.1517/13543784.11.6.859

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.11.6.859

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.11.6.859

Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.11.6.859

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.11.6.859

RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.11.6.859

Rational design of potent sialidase-based inhibitors of influenza virus replication

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS.

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Oseltamivir: a clinical and pharmacological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Neuraminidase inhibitors for the treatment and prevention of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Progressive Murine Cytomegalovirus Disease after Termination of Ganciclovir Therapy in Mice Immunosuppressed by Cyclophosphamide Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859

Resistance of influenza viruses to neuraminidase inhibitors--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.6.859